Newsroom

Sorted by: Latest

-

Redwood Trust Announces Third Quarter 2026 Common and Preferred Dividends

MILL VALLEY, Calif.--(BUSINESS WIRE)--Redwood Trust, Inc. (NYSE: RWT; “Redwood” or the “Company”), a leader in expanding access to housing for homebuyers and renters, today announced that its Board of Directors (the “Board”) has declared third quarter 2026 common and preferred stock dividends.Common Stock DividendThe Board has authorized the declaration of a third quarter 2026 regular common stock dividend of $0.18 per share, unchanged from the second quarter of 2026. This marks the Company's 10...
-

One Biosciences Receives €3,3 Million Funding Under i-Démo 5 From France 2030 to Accelerate Development of First Single-Cell Diagnostic for Triple-Negative Breast Cancer, in Collaboration With Institut Curie

PARIS--(BUSINESS WIRE)--One Biosciences receives funding to develop the first single-cell profiling diagnostic to inform treatment decisions in triple negative breast cancer...
-

BDC Report: $11 Billion in ‘Big Six’ Gas Pipeline Spending Drives 67% Surge in Pennsylvania Gas Utility Bills

HARRISBURG, Pa.--(BUSINESS WIRE)--67% increase in Pennsylvania gas utility bills driven by $11 billion in ‘Big Six’ gas pipeline spending, BDC Reports....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Cybersecurity UCITS ETF 09.09.2026 NQCYBREN IE00BF16M727 27,785,554.00 USD 1,632,102,493.48   58.739  ...
-

Definium Therapeutics to Present Topline Data from Phase 3 Emerge and Voyage Trials Across Major Depressive Disorder and Generalized Anxiety Disorder at Psych Congress 2026

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced six poster presentations at the Psych Congress taking place September 15 through 19 in New Orleans, LA. “This year at Psych Congress, we will share clinical findings from our DT120 Orally Disintegrating Tablet Phase 3 clinic...
-

Alkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards® Program

DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today announced that it will begin accepting applications for its annual Alkermes Pathways Research Awards® program on Friday, Sept. 11, 2026. Now in its ninth year, this competitive grant program is designed to support the next generation of researchers working on the front lines to advance our understanding of diseases in the field of neuroscience. Building on prior award cycles, the program will continue to accept applications related to s...
-

Mitutoyo America Corporation Releases New Comprehensive Measuring Instruments Catalog

AURORA, Ill.--(BUSINESS WIRE)--Explore the new Mitutoyo Measuring Instruments Catalog, featuring 5,500+ precision measurement and metrology products, tools and technologies....
-

AM Best to Join Panel Discussion on Emerging Risks at Latin America Reinsurance Group’s Annual Meeting

MEXICO CITY--(BUSINESS WIRE)--AM Best will join a panel discussion during the Latin America Reinsurance Group’s (LARG) 2026 Annual Meeting, which will take place Sept. 23–26, 2026, in Guatemala City, Guatemala. Carlos De la Torre, managing director of operations of AM Best’s Mexico-based subsidiary, will participate in a panel discussion titled “Emerging Risks and its future impact for the Insurance and Reinsurance market,” to explore how emerging macroeconomic, climate, technological and struc...
-

STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today released a new report entitled The Future of Refractive Surgery, the first comprehensive global market analysis showing a consistent, multi-market migration toward implantable lens correction driven by durable tailwinds on the demand and clinical sides of the market. The report examines patient...
-

TrustPointAI Names Real Estate Data Veteran Shannon Norris as Head of Client Relationships

SAN MATEO, Calif.--(BUSINESS WIRE)--TrustPointAI, the innovation leader in asset and portfolio management (APM) technology for construction, renovation, bridge, and land development lending, today announced the appointment of Shannon Norris as Head of Client Relationships. Norris will lead TrustPointAI's growing client relationship team, partnering with company leadership to build the executive relationships that keep the company a strategic partner to every client it serves.“Shannon has an exce...